Novartis in top Swiss dividend stocks

Investors in Novartis can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Analysts expect a dividend of 3,12 CHF per share. Thus the dividend yield equals 3,63 percent. The average dividend yield of the pharmaceutical companies is an attractive 6,35 percent.

Historical dividend returns Novartis

Tomorrow the Swiss Novartis will report its past quarters results. Over the current book year the total revenue will be 50,21 billion CHF (consensus estimates). This is slightly more than 2018's revenue of 48,62 billion CHF.

Historical revenues and results Novartis plus estimates 2020

The analysts expect for 2020 a net profit of 12,93 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 5,7 CHF. The PE-ratio therefore is 15,08.

Latest estimates around 93 CHF

Based on the current number of outstanding shares Novartis's market capitalization is 198,69 billion CHF. The Novartis stock was the past 12 months quite unstable. Since last April the stock is 8 percent higher. This year the stock price moved between 65 and 96 CHF. Since 2008 the stock price is almost 76 percent higher.

Historical stock prices Novartis

Click here for dividend . At 13.26 the stock trades 2,27 percent higher at 85,97 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.